Beyond hepatocellular carcinoma (HCC), studies have demonstrated that OGDHL expression is frequently silenced by cancer-specific promoter methylation in lung, breast, cervix, esophagus, pancreas, renal cell carcinoma and colon cancers [53,63,64,65,66,67,68]. Here, OGDHL is linked to hepatocellular carcinoma.